Trials / Completed
CompletedNCT00691743
Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 850 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current epidemiological study will be undertaken in GP's and specialized private doctors. In total, 85 general practitioners, orthopedics, rheumatologists and cardiologist will take part in the study. Data will be collected for 850 patients who visit their physician for medical conditions that require the use of acetylsalicylic acid and/or NSAIDS. The first 10 consecutive patients who visit their GP/orthopedic/rheumatologist/cardiologists and are currently receiving acetylsalicylic acid and/or NSAIDS will be included in the study.
Conditions
Timeline
- Start date
- 2008-03-01
- Completion
- 2008-12-01
- First posted
- 2008-06-05
- Last updated
- 2009-01-12
Locations
27 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT00691743. Inclusion in this directory is not an endorsement.